Nebulized fentanyl for respiratory symptoms in patients with COVID-19 (ventanyl trial)
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000028637
Abstract: Abstract Patients with coronavirus disease (COVID-19) commonly experience distressing and challenging respiratory symptoms. Interventions such as oxygen therapy, oral opiates, and traditional nebulizers like ipratropium bromide and salbutamol are variable in their efficacy, and therapy… read more here.
Keywords: patients covid; respiratory symptoms; throat pain; nebulized fentanyl ... See more keywords